Fred Hutchinson Cancer Research Center, Seattle
New research from the United States and Canada in the area of herpes detailed
Published in Law and Health Weekly, June 24th, 2006
Study 1: A replication-defective (GH deletion) herpes simplex virus vaccine was not effective for the treatment of recurrent genital herpes among immunocompetent subjects.
According to a study from the United States, "A replication incompetent herpes virus lacking the glycoprotein H gene has been developed as a potential therapeutic vaccine for genital herpes. [The goal was] to determine vaccine efficacy on reducing HSV reactivation and clinical disease among immunocompetent persons with recurrent genital HSV-2 infection. [The study was a] randomized multicenter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biotechnology Industry Organization
BIO names Tom DiLenge as general counsel - Centro Nacional de Biotecnologia, Madrid
Recent findings from Spain, the United States and Canada illuminate research in vaccines - Chimerix, Inc.
Chimerix acquires lead compound library of antiviral agents from University of Michigan - City of Hope National Medical Center, Duarte
RNAi is developed as treatment for HIV-1 infection - Federal University of Minas Gerais
Researchers from Brazil, Italy and Portugal provide details of new studies and findings in the area of obesity - Free University of Amsterdam
Free University of Amsterdam researchers describe recent findings - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
